BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24938321)

  • 1. Valsartan prevents neointimal hyperplasia after carotid artery stenting by suppressing endothelial cell injuries.
    Suzuki H; Sano T; Umeda Y; Yamamoto A; Toma N; Sakaida H; Taki W
    Neurol Res; 2015 Jan; 37(1):35-42. PubMed ID: 24938321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II type 1 receptor blockers suppress neointimal hyperplasia after stent implantation in carotid arteries of hypercholesterolemic rabbits.
    Ichikawa N; Toma N; Kawakita F; Matsushima S; Imanaka-Yoshida K; Yoshida T; Taki W; Suzuki HI
    Neurol Res; 2015 Feb; 37(2):147-52. PubMed ID: 25089806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin receptor blocker added to previous antihypertensive agents on arteries of diabetic hypertensive patients.
    Savoia C; Touyz RM; Endemann DH; Pu Q; Ko EA; De Ciuceis C; Schiffrin EL
    Hypertension; 2006 Aug; 48(2):271-7. PubMed ID: 16785331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of clopidogrel loading dose on peripheral blood endothelial progenitor cells, SDF-1α and neointimal hyperplasia in carotid stenting.
    Di Stolfo G; Mastroianno S; Ruggieri M; Fontana A; Marinucci R; Copetti M; Minervini MM; Savino L; Mastroianno M; Savino M; Pacilli MA; Di Mauro L; Potenza DR; Cascavilla N; Paroni G; Russo A
    Clin Hemorheol Microcirc; 2019; 72(1):23-38. PubMed ID: 30320560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of combination of valsartan and amlodipine on salt-induced brain injury in hypertensive rats.
    Dong YF; Kataoka K; Tokutomi Y; Nako H; Nakamura T; Toyama K; Sueta D; Koibuchi N; Yamamoto E; Ogawa H; Kim-Mitsuyama S
    J Pharmacol Exp Ther; 2011 Nov; 339(2):358-66. PubMed ID: 21807884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of angiotensin II receptor blockade with valsartan on carotid arterial stiffness and hemodynamic alterations in patients with essential hypertension.
    Okura T; Watanabe S; Kurata M; Koresawa M; Irita J; Enomoto D; Jotoku M; Miyoshi K; Fukuoka T; Higaki J
    Clin Exp Hypertens; 2008 Jul; 30(5):415-22. PubMed ID: 18633763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The comparative effects of valsartan and amlodipine on vWf levels and N/L ratio in patients with newly diagnosed hypertension.
    Karaman M; Balta S; Seyit Ahmet AY; Cakar M; Naharci I; Demirkol S; Celik T; Arslan Z; Kurt O; Kocak N; Sarlak H; Demirbas S; Bulucu F; Bozoglu E
    Clin Exp Hypertens; 2013; 35(7):516-22. PubMed ID: 23289969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of valsartan or amlodipine on endothelial function and oxidative stress after one year follow-up in patients with essential hypertension.
    Hirooka Y; Kimura Y; Sagara Y; Ito K; Sunagawa K
    Clin Exp Hypertens; 2008 Apr; 30(3):267-76. PubMed ID: 18425706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-stent hypodense area at two weeks following carotid artery stenting predicts neointimal hyperplasia after two years.
    Yamashita K; Kokuzawa J; Kuroda T; Murase S; Kumagai M; Kaku Y
    Neuroradiol J; 2018 Jun; 31(3):280-287. PubMed ID: 28816615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of the renoprotective effects of benidipine and valsartan in primary hypertensive patients with proteinuria.
    Peng T; Hu Z; Xia Q; Jiang B; Li X; Yang X
    Arzneimittelforschung; 2009; 59(12):647-50. PubMed ID: 20108651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials.
    Wang JG; Staessen JA; Li Y; Van Bortel LM; Nawrot T; Fagard R; Messerli FH; Safar M
    Stroke; 2006 Jul; 37(7):1933-40. PubMed ID: 16763185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valsartan decreases neointimal hyperplasia in balloon-injured rat aortic arteries by upregulating HO-1 and inhibiting angiotensin II type 1 receptor.
    Li Y; Wang Q; Xu Q; Cai S; Zhou J; Ren B; Sun T; Liu X; Yu H
    Life Sci; 2014 Aug; 110(2):70-6. PubMed ID: 25014676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients.
    Savoia C; Touyz RM; Volpe M; Schiffrin EL
    Hypertension; 2007 Feb; 49(2):341-6. PubMed ID: 17159079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duplex ultrasound velocity criteria for the stented carotid artery.
    Lal BK; Hobson RW; Tofighi B; Kapadia I; Cuadra S; Jamil Z
    J Vasc Surg; 2008 Jan; 47(1):63-73. PubMed ID: 18178455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is renoprotection by angiotensin receptor blocker dependent on blood pressure?: the Saitama Medical School, Albuminuria Reduction in Diabetics with Valsartan (STAR) study.
    Katayama S; Yagi S; Yamamoto H; Yamaguchi M; Izumida T; Noguchi Y; Inaba M; Inukai K
    Hypertens Res; 2007 Jun; 30(6):529-33. PubMed ID: 17664856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive rats.
    Takai S; Jin D; Aritomi S; Niinuma K; Miyazaki M
    Hypertens Res; 2013 Apr; 36(4):342-8. PubMed ID: 23190689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of P-selectin, von Willebrand and endothelin-1 after carotid artery stenting.
    Xia ZY; Yang H; Qu HQ; Cheng WD; Wang LX
    Vasa; 2011 May; 40(3):199-204. PubMed ID: 21638248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valsartan reduces serum cystatin C and the renal vascular resistance in patients with essential hypertension.
    Watanabe S; Okura T; Kurata M; Irita J; Manabe S; Miyoshi K; Fukuoka T; Gotoh A; Uchida K; Higaki J
    Clin Exp Hypertens; 2006 Jul; 28(5):451-61. PubMed ID: 16820342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Valsartan eluting-stents inhibited neointimal hyperplasia by decreasing collagen deposition in rabbits].
    Wang L; Jia SQ; Li GH; Chen H; Li HW; Zhao L; Yao DK; Ding RJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 May; 34(5):450-3. PubMed ID: 16776965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amlodipine seems to be superior to valsartan in decreasing microalbuminuria in newly diagnosed hypertensive patients: a novel effect to be explained with hyperfiltration?
    Ay SA; Cakar M; Karaman M; Balta S; Demirkol S; Unlu M; Kurt O; Altun B; Akhan M; Arslan E; Koc B; Bulucu F
    Ren Fail; 2013; 35(3):357-60. PubMed ID: 23297711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.